Company Monitoring Page for Avanir

latest headlines for company on cafepharma

Reeling from a hefty civil and criminal settlement, Avanir stumbles into PhIII Alzheimer's failure
Endpoints
Mon, 09/30/19 - 10:34 am
Tags:
Avanir, Alzheimer's disease, clinical trials, Nuedexta
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop
Motley Fool
Sat, 03/30/19 - 12:44 pm
Tags:
Alzheimer's disease, Biogen, aducanumab, Otsuka, Axsome Therapeutics, Amgen, Novartis, Avanir, AVP-786, AXS-05, AMG520
Users Respond to CNN article on Nuedexta
CP Wire
Fri, 10/13/17 - 09:45 am
Tags:
CNN, Avanir, Nuedexta, cafepharma
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
Tags:
biotech, Avanir, OvaScience, Agios, Bluebird Bio, Receptos, Prosensa, Pernix, Achillion, Amicus Therapeutics, CytoSorbents, PTC Therapeutics
Otsuka May Have Undervalued Avanir’s (AVNR) Bid; Shareholders Worried
Bidness Etc.
Fri, 12/5/14 - 11:01 am
Tags:
Otsuka, M&A, Avanir
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
Fortune
Tue, 12/2/14 - 08:39 am
Tags:
Otsuka, M&A, Avanir
FDA rejects Avanir's migraine drug-device
Yahoo/Reuters
Wed, 11/26/14 - 11:33 pm
Tags:
FDA, Avanir, migraines, AVP-825
FDA approval unlikely as PDUFA date approaches for Avanir
Seeking Alpha
Fri, 11/21/14 - 11:19 am
Tags:
FDA, Avanir, migraines, AVP-825
Avanir's AVP-825 Approval Could be Delayed
Yahoo/Zacks.com
Wed, 11/12/14 - 08:35 am
Tags:
Avanir, AVP-825, migraines
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thu, 10/30/14 - 12:22 pm
Tags:
M&A, Avanir, Alzheimer's disease, Lundbeck, Eli Lilly, Mallinckrodt, Shire
Avanir's Over-Priced Cough Syrup Touted For Role in Alzheimer's Agitation
TheStreet.com
Mon, 09/15/14 - 11:37 am
Tags:
Avanir, Alzheimer's disease, AVP-923
Avanir Pharmaceuticals: Riding On A Non-Fundamental Catalyst
Seeking Alpha
Fri, 05/2/14 - 10:48 am
Tags:
Avanir, Neudexta
Impax, Par Pharmaceutical stayed from selling generic version of Avanir drug
The Fly on the Wall
Wed, 03/19/14 - 11:05 am
Tags:
Impax Laboratories, Avanir, generics, Par Pharmaceutical, Nuedexta
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Motley Fool
Wed, 02/5/14 - 06:56 pm
Tags:
earnings, Avanir
3 Companies Working on Parkinson's Treatments You Ought to Know About
Motley Fool
Wed, 01/29/14 - 05:42 pm
Tags:
Parkinson's Disease, Chelsea Therapeutics, Prothena, Avanir, AVP-923, Northera, PRX-002
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Mon, 01/27/14 - 09:21 am
Tags:
Avanir, BioDelivery Sciences, Conatus Pharmaceuticals, Geron, Halozyme, Neurocrine, Orexigen
Avanir Gives Preliminary Q1 Update
Yahoo/Zacks.com
Tue, 01/14/14 - 04:27 pm
Tags:
Avanir, earnings
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Fri, 01/10/14 - 10:34 am
Tags:
Ampio, Avanir, Chelsea Therapeutics, Endo Health Solutions, Optina, Northera, Synergy Pharmaceuticals, plecanatide, AVP-825, vintafolide
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 09/14/13 - 11:01 am
Tags:
Neurocrine Biosciences, ChemoCentryx, GSK, Avanir
Avanir, Sandoz settle Nuedexta patent litigation
Pharmaceutical Business Review
Fri, 08/16/13 - 10:55 am
Tags:
Avanir, Sanzoz, patents, generics, Novartis, Nuedexta

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.